BCRX R&D to Revenue
Biocryst Pharmaceuticals Inc · R&D to Revenue
BCRX R&D to Revenue
Latest reported18.99%period ending
BCRX FY R&D/Revenue (0.00% → 18.99%)
Latest values, visible window
High-resolution chart · PNG
BCRX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 18.9894% | |
| 38.7471% | |
| 65.3465% | |
| 93.5272% | |
| 132.8549% | |
| 690.3436% | |
| 219.2444% | |
| 411.0202% | |
| 265.8699% | |
| 231.5031% | |
| 150.7719% | |
| 380.629% | |
| 246.5524% | |
| 195.7327% | |
| 289.6604% | |
| 129.8767% | |
| 96.9339% | |
| 129.6408% | |
| 132.0252% | |
| 757.95% | |
| 15,567.8172% | |
| 5,600.4915% | |
| 705.1408% | |
| 871.9798% | |
| 117.3283% | |
| 289.2499% | |
| 308% | |
| 145.3125% | |
| 1,060% | |
| 0% | |
| 0% | |
| 0% |